Body fat distribution and associations with metabolic and clinical characteristics in bipolar individuals

European Archives of Psychiatry and Clinical Neuroscience

Volumn 265, Issue 4, 2015, Pages 313-319

  Lackner, Nina ^a   Mangge, Harald ^a   Reininghaus, Eva Z ^a   McIntyre, Roger S ^b   Bengesser, Susanne A ^a   Birner, Armin ^a   Reininghaus, Bernd ^a   Kapfhammer, Hans Peter ^a   Wallner Liebmann, Sandra J ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bipolar disorder; Body composition; Central obesity; Metabolic syndrome; Staging; Subcutaneous adipose tissue thickness

Indexed keywords

ADRENALIN; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; MONOAMINE; BIOGENIC AMINE;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ANTHROPOMETRY; ANTICONVULSANT THERAPY; ARTICLE; AUSTRIAN; BIPOLAR DISORDER; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HIP CIRCUMFERENCE; HUMAN; LIPOMETRY; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; STAGING; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; ADIPOSE TISSUE; BLOOD; COMPLICATION; LIFESTYLE; METABOLIC DISEASES; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SEX DIFFERENCE; YOUNG ADULT;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; BIOGENIC MONOAMINES; BIPOLAR DISORDER; BODY FAT DISTRIBUTION; BODY MASS INDEX; COHORT STUDIES; FASTING; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC DISEASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; SURVEYS AND QUESTIONNAIRES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84939417969     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-014-0559-8     Document Type: Article

References (28)

1. McIntyre RS, Konarski JZ, Wilkins K, Soczynska JK, Kennedy SH (2008) Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being. Can J Psychiatry 51:274–280
2. Chauvet-Gélinier JC, Gaubil I, Kaladjian A, Bonin B (2012) Bipolar disorders and somatic comorbidities: a focus on metabolic syndrome, diabetes and cardiovascular disease. L’Encephale 38:167–172
3. Czepielewski L, Daruy Filho L, Brietzke E, Grassi-Oliveira R (2013) Bipolar disorder and metabolic syndrome: a systematic review. Rev Bras Psiquiatr 35:88–93
4. Fagiolini A, Chengappa KN, Soreca I, Chang J (2008) Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden. CNS drugs 22:655–669
5. Hung CI, Liu CY, Hsiao MC, Yu NW, Chu CL (2014) Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders. BMC psychiatry 14:185
6. McElroy SL, Keck PE Jr (2014) Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression. J Clin Psychiatry 75:46–61
7. McIntyre RS, Woldeyohannes HO, Soczynska JK, Miranda A, Lachowski A, Liauw SS, Kennedy SH (2010) The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder. Adv Ther 27:828–836
8. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M (2008) Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a health management organization database. Bipolar Disord 10:607–616
9. Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN (2005) Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management. Encephale 31:507–516
10. Maina G, Salvi V, Vitalucci A, D’Ambrosio V, Bogetto F (2008) Prevalence and correlates of overweight in drug-naive individuals with bipolar disorder. J Affect Disord 110:149–155
11. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB (2004) Are mood disorders and obesity related? a review for the mental health professional. J Clin Psychiatry 65:634–651
12. Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E (2003) Obesity as a correlate of outcome in individuals with bipolar I disorder. Am J Psychiatry 160:112–117
13. Calkin C, Van de Velde C, Růžičková M, Slaney C, Garnham J, Hajek T, Alda M (2009) Can body mass index help predict outcome in individuals with bipolar disorder? Bipolar Disord 11:650–656
14. Goldstein BI, Liu SM, Zivkovic N, Schaffer A, Chien LC, Blanco C (2011) The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord 13:387–395
15. Yim CY, Soczynska JK, Kennedy SH, Woldeyohannes HO, Brietzke E, McIntyre RS (2011) The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Eur Psychiatry 27:223–228
16. Ludescher B, Machann J, Eschweiler GW, Thamer C, Maenz C, Hipp A, et al (2011) Active depression is associated with regional adiposity in the upper abdomen and the neck. Int J Psychiatry Med 41:271–280
17. Möller R, Tafeit E, Pieber TR, Sudi K, Reibnegger G (2000) Measurement of subcutaneous adipose tissue topography (SAT-Top) by means of a new optical device, LIPOMETER, and the evaluation of standard factor coefficients in healthy subjects. Am J Hum Biol 12:231–239
18. Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9:957–966
19. Zimmet P, Alberti KGMM, Serrano Ríos M (2005) A new International Diabetes Federation (IDF) worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol (English Edition) 58:1371–1375
20. Rieder A, Rathmanner T, Kiefer I, Dorner T, Kunze M (2004) Österreichischer Diabetesbericht 2004: Daten, Fakten, Strategien. Bundesministerium für Gesundheit und Frauen, Wien
21. Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11–18
22. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, O’Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48
23. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D (2010) Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 17:4511–4520
24. Mangge H, Summers KL, Meinitzer A, Zelzer S, Almer G, Prassl R et al (2014) Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity 22:195–201
25. Tsigos C, Chrousos GP (2003) Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865–871
26. Berrettini WH, Nurnberger JI Jr, Scheinin M, Seppala T, Linnoila M, Narrow W, Simmons-Alling S, Gershon ES (1985) Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients. Biol Psychiatry 20:257–269
27. Mansur RB, Cha DS, Asevedo E, McIntyre RS, Brietzke E (2013) Selfish brain and neuroprogression in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 43:66–71
28. Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, Schultes B, Born J, Fehm HL (2004) The selfish brain: competition for energy resources. Neurosci Biobehav Rev 28:143–180